PMID- 21933601 OWN - NLM STAT- MEDLINE DCOM- 20120427 LR - 20110921 IS - 2542-5641 (Electronic) IS - 0366-6999 (Linking) VI - 124 IP - 16 DP - 2011 Aug TI - Perfluorocarbon attenuates lipopolysaccharide-mediated inflammatory responses of alveolar epithelial cells in vitro. PG - 2534-9 AB - BACKGROUND: Toll-like receptor-4 (TLR-4) is integrally involved in lipopolysaccharide (LPS) signaling and has a requisite role in the activation of nuclear factor-kappaB (NF-kappaB). The exact mechanisms that lend perfluorocarbon (PFC) liquids a cytoprotective effect have yet to be elucidated. Therefore we examined in an in vitro model the cytoprotective effect of PFC on LPS-stimulated alveolar epithelial cellls (AECs). METHODS: AECs (A549 cells, human lung adenocarcinoma cell line) were divided into four groups: control, PFC, LPS and LPS + PFC (coculture group) groups. Intercellular adhesion molecule-1 (ICAM-1) was detected by ELISA, tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) were detected by radioimmunological methods. The expression of TLR-4 mRNA and protein was detected by real time PCR and Western blotting, respectively. The activation of NF-kappaB was detected by Western blotting (proteins of I-kappaBa and NF-kappaB p65). RESULTS: ICAM-1, TNF-alpha and IL-8 were significantly increased in LPS-stimulated AECs groups. The expression of TLR-4 mRNA and protein in LPS-stimulated groups was markedly increased. Meanwhile, NF-kappaB was activated as indicated by the significant degradation of IkappaB-alpha and the significant release of NF-kappaB P65 and its subsequent translocation into the nucleus. There were no significant effects of PFC alone on any of the factors studied while the coculture group showed significant downregulation of the secretion of ICAM-1, TNF-alpha and IL-8, the expression of TLR-4 mRNA and the activity of NF-kappaB. CONCLUSIONS: Taken together, our results demonstrate that LPS can induce AEC-related inflammatory injury via the activation of TLR-4 and subsequent activation of NF-kappaB. PFC is able to protect AECs from LPS-induced inflammatory injury by blocking the initiation of the LPS signaling pathway, which is indicated by the significant decrease of TLR-4 expression and NF-kappaB activation. FAU - Xu, Shu-Feng AU - Xu SF AD - Department of Respiratory Medicine, Chinese People's Liberation Army General Hospital, Beijing 100853, China. FAU - Wang, Ping AU - Wang P FAU - Liu, Rui-Ji AU - Liu RJ FAU - Zhao, Jing AU - Zhao J FAU - Zhang, Xiang-Ning AU - Zhang XN FAU - Fu, Zhan-Zhao AU - Fu ZZ FAU - Gao, Li-Ming AU - Gao LM FAU - Liang, Zhi-Xin AU - Liang ZX FAU - Sun, Ji-Ping AU - Sun JP FAU - Chen, Liang-An AU - Chen LA LA - eng PT - Journal Article PL - China TA - Chin Med J (Engl) JT - Chinese medical journal JID - 7513795 RN - 0 (Fluorocarbons) RN - 0 (Interleukin-8) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) SB - IM MH - Blotting, Western MH - Cell Line, Tumor MH - Epithelial Cells/*drug effects/*immunology MH - Fluorocarbons/*pharmacology MH - Humans MH - Inflammation/chemically induced/*immunology MH - Intercellular Adhesion Molecule-1/genetics/metabolism MH - Interleukin-8/genetics/metabolism MH - Lipopolysaccharides/*pharmacology MH - NF-kappa B/genetics/metabolism MH - Pulmonary Alveoli/*cytology MH - Real-Time Polymerase Chain Reaction MH - Toll-Like Receptor 4/genetics/metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism EDAT- 2011/09/22 06:00 MHDA- 2012/04/28 06:00 CRDT- 2011/09/22 06:00 PHST- 2011/09/22 06:00 [entrez] PHST- 2011/09/22 06:00 [pubmed] PHST- 2012/04/28 06:00 [medline] PST - ppublish SO - Chin Med J (Engl). 2011 Aug;124(16):2534-9.